Navigation Links
Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
Date:11/5/2009

hich may result in the discontinuation or delay of the research or development projects; the risk of technical obsolescence; the need for further regulatory approvals, which may not be obtained in a timely matter or at all; intellectual property risks, including without limitation, the risk that three patents for Topical Interferon Alpha-2b will expire in 2013 and no additional patent may be issued, that patent applications may not result in issued patents, that issued patents may be circumvented or struck down, and the risk of potential claims of infringement by the Company of third party intellectual property rights; marketing/manufacturing and partnership/strategic alliance risks; the effect of competition; uncertainty of the size and existence of a market opportunity for Helix's product; the risk that the Company's supplier of interferon alpha-2b may not continue to provide the Company with interferon alpha-2b or exercise its commercialization option, which would have a negative effect on the further development of the drug candidate and on the Company; and the risk of changes in business strategy or development plans. Certain of these risks and uncertainties, and others affecting the Company which could cause actual results to vary materially from current results or those anticipated in forward-looking statements and information, are more fully described in the Company's latest MD&A, Form20-F and other reports filed with the Canadian Securities Regulatory Authorities and the U.S. SEC from time to time at www.sedar.com and www.sec.gov/edgar.shtml, respectively. Forward-looking statements and information are based on the beliefs, assumptions, opinions and expectations of Helix's management at the time they are made, and Helix does not assume any obligation to update any forward-looking statement or information should those beliefs, assumptions, opinions or expectations change, except as required by law.


'/>"/>
SOURCE Helix BioPharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Helix BioPharma Corp. Announces Fiscal 2009 Results
2. Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA
3. J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory
4. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
5. PDL BioPharma Announces Closing of $300,000,000 Securitization Transaction
6. Lilly CEO Lechleiter Calls for Repair of the Engine of Biopharma Innovation
7. NeoStem Acquires China Biopharmaceuticals Holdings, Inc.; Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company
8. China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol NBS
9. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego
10. NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
11. Laureate Pharma Announces Signing New Biopharmaceutical Development & Manufacturing Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... CHAPEL HILL, N.C. , July 11, 2014 ... research analysis approaches are evolving across industry sectors ... are now examining better ways to engage with ... how consumers inform themselves and make critical purchasing ... by benchmarking firm, Best Practices, LLC, one area ...
(Date:7/11/2014)... Research and Markets has announced ... X-ray Film Industry Report 2014" report to their ... Global And Chinese Medical X-Ray Film Industry Report ... current state of the Global medical X-ray film industry ... report provides a basic overview of the industry including ...
(Date:7/11/2014)... 11, 2014 Research and Markets  has ... Market 2014-2018" report to their offering. ... needle is a hollow needle commonly used with a ... to extract fluids from it. A hypodermic needle is ... substances that cannot be ingested. Hypodermic needles are broadly ...
Breaking Medicine Technology:New Technologies Transforming Consumer Marketing Research Playbook 2Global and Chinese Medical X-ray Film Industry Report 2014 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 3
... BioTrends Research Group, Inc. recently published its ... is based on online survey ... radiologists and interventional nephrologists). It provides an in-depth view ... patterns related to both vascular access placement and maintenance. ...
... Aug. 24 Sunridge International (OTC Bulletin Board: ... next month to have meetings with key brokers and funds. ... to our company,s technology, and to facilitate funding for Sunridge ... "Now is a good time for this project," states G. ...
Cached Medicine Technology:Latest BioTrends Report Provides Comprehensive Market Landscape of the Dialysis Vascular Access Market 2
(Date:7/14/2014)... Botanica Day Spa announced last month that their ... the day spa in down town Clearwater, FL on ... refreshments will be served as clients are invited to ... and great deals on spa services, including the ... (also known as “facial shaving”) is a simple and ...
(Date:7/14/2014)... 2014 (HealthDay News) -- Eye tests could be used ... disease, two new studies suggest. In one study, ... eye test found a significant association between levels of ... levels of the plaques in the brain. Beta-amyloid plaques ... This type of eye test could be used in ...
(Date:7/14/2014)... News) -- Stress can slow a woman,s metabolism and lead ... 58 women, average age 53, who were asked about their ... than included 930 calories and 60 grams of fat. The ... women to burn off those calories and fat. On ... the previous 24 hours burned 104 fewer calories in the ...
(Date:7/14/2014)... (PRWEB) July 14, 2014 ... Ultra performance liquid chromatography or UPLC is ... of liquid chromatography that involves the use ... conditions to separate chromatographic compounds. This highly ... faster detection and analysis of chromatography samples. ...
(Date:7/14/2014)... Atlanta, GA (PRWEB) July 14, 2014 ... networking and relationship-marketing firm, announced today that nominations ... for the 2014 Information Security Executive® (ISE®) North ... Security Executive® of the Year, which recognizes executives ... organizations through risk management, data-asset protection, regulatory compliance, ...
Breaking Medicine News(10 mins):Health News:Botanica Day Spa to Feature Dermaplaning at Upcoming Open House 2Health News:Botanica Day Spa to Feature Dermaplaning at Upcoming Open House 3Health News:Eye Tests Might Help ID Alzheimer's, Studies Suggest 2Health News:Stress May Leave You Heading to the Cookie Jar 2Health News:Need for Faster Sample Analysis Drives Demand for UPLC, According to New Trend Report Published by Global Industry Analysts, Inc. 2Health News:T.E.N. Accepting Nominations for the 2014 Information Security Executive® North America Awards 2Health News:T.E.N. Accepting Nominations for the 2014 Information Security Executive® North America Awards 3
... Teriparatide may help asthma patients avoid fracture, researchers ... A new drug has proven superior to standard ... treatment, researchers say. , Glucocorticoid medicines such as ... disorders, skin allergies and other conditions, researchers note. ...
... suspect it may cause airway inflammation, , , WEDNESDAY, Nov. 14 ... to help protect the airways now appears to be a ... a role in the development of asthma, according to new ... New England Journal of Medicine , Yale University researchers ...
... Researchers at the Medical College of Wisconsin in Milwaukee ... normal tissue after exposure may be reduced by a ... in the on line issue of the International Journal ... that long-term administration of the drug captopril, starting at ...
... data on worldwide cancer incidence, researchers at the Moores ... have shown a clear association between deficiency in exposure ... , UVB exposure triggers photosynthesis of vitamin D3 ... also available through diet and supplements. Previous studies from ...
... scientists say , , WEDNESDAY, Nov. 14 (HealthDay News) -- ... Alzheimer,s diagnosis than white patients, a new study suggests. ... Indian descent diagnosed with the disease were found to ... patients, patients of Hispanic or black ethnicity were ...
... 14 Biodel Inc. (Nasdaq:,BIOD) today announced that ... Financial Officer, Vice President of Corporate Development,and Treasurer, ... to welcome Gerard to our team," said Dr. ... in executing,complex financial transactions and negotiating marketing partnerships ...
Cached Medicine News:Health News:New Drug Fights Medication-Linked Bone Loss 2Health News:Defensive Protein Linked to Asthma 2Health News:Defensive Protein Linked to Asthma 3Health News:Medical College of Wisconsin study finds drug may limit radiation kidney damage in BMT patients 2Health News:Global view shows link between endometrial cancer and vitamin D status 2Health News:Blacks, Hispanics Live Longer With Alzheimer's 2Health News:Blacks, Hispanics Live Longer With Alzheimer's 3Health News:Blacks, Hispanics Live Longer With Alzheimer's 4Health News:Biodel Inc. Announces Appointment of Gerard Michel as CFO, VP of Corporate Development and Treasurer 2Health News:Biodel Inc. Announces Appointment of Gerard Michel as CFO, VP of Corporate Development and Treasurer 3
The Acute Care myoglobin method is an in vitro diagnostic test for the measurement of myoglobin in heparinized whole blood /plasma. Myoglobin measurements can be used as an aid in diagnosing myocardi...
... are used by hospitals, clinics and the ... health conditions. The majority of these products ... are offered in strip, cassette, and stick ... membrane tests are also available. All require ...
... The CALBIOTECH INC. (CBI) Prolactin ELISA ... of prolactin in human serum or plasma. ... chain polypeptide hormone with a molecular weight ... is based on a solid phase direct ...
... is a polypeptide hormone secreted in significant ... the placenta. Prolactin, in synergy with estrogen, ... initiation and maintenance of mammary gland growth ... prolactin may have effects on cell growth ...
Medicine Products: